Ibudilast: a non-selective phosphodiesterase inhibitor in brain disorders
Joanna Schwenkgrub(Centre National de la Recherche Scientifique), Iwona Kurkowska‐Jastrzębska(Institute of Psychiatry and Neurology), M Zaremba(Medical University of Warsaw), Dagmara Mirowska-Guzeł(Medical University of Warsaw)
Cited by 23
Related Papers
The phosphodiesterase inhibitor, ibudilast, attenuates neuroinflammation in the MPTP model of Parkinson’s disease
|PLoS ONE|2017|53
The influence of AAV2-mediated gene transfer of human IL-10 on neurodegeneration and immune response in a murine model of Parkinson's disease
|Pharmacological Reports|2014|44
Awake perception is associated with dedicated neuronal assemblies in the cerebral cortex
|Nature Neuroscience|2022|42
Effect of human interleukin-10 on the expression of nitric oxide synthases in the MPTP-based model of Parkinson's disease
|Pharmacological Reports|2013|34
Deep imaging in the brainstem reveals functional heterogeneity in V2a neurons controlling locomotion
|Science Advances|2020|26